Founded with technology developed in Professor George Church's lab at Harvard Medical School, GC Therapeutics is a synthetic biology company focused on programming patient-derived stem cells into any cell type efficiently and scalably. Their core mission is to revolutionize cell therapy by creating customizable SuperCells™ for various medical applications. The company aims to streamline the process of dictating cell fates in a single step, thereby accelerating the development of personalized treatments.

Notable affiliated individuals include Professor George Church, a pioneer in synthetic biology. GC Therapeutics has achieved significant milestones in verifying cells for multiple applications, demonstrating the potential of their technology in real-world scenarios. Their innovative approach has positioned them as a key player in the synthetic biology market, promising substantial impact on the future of personalized medicine and cell therapy.